Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 8/20 | 0.65 |
| ▸ | MAPT | P10636 | 8/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.65 |
| ▸ | MEN1 | O00255 | 6/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.65 |
| ▸ | GLA | P06280 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | CDC25B | P30305 | 6/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 5/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11962221 | 0.87 | GAA (0.85) | GAAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL22562123 | 0.82 | CDC25B (0.50) | GAAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL11792861 | 0.81 | GAA (0.55) | GAAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL30997736 | 0.80 | MEN1 (0.74) | GAAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL11883944 | 0.80 | MEN1 (0.74) | GAAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL6404861 | 0.80 | MEN1 (1.00) | GAAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL5605050 | 0.78 | MAPT (0.61) | GAAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL5605493 | 0.78 | MAPT (0.61) | GAAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL23507939 | 0.77 | CDC25B (0.47) | GAAMAPTKDM4EMEN1KMT2A | |
| SCHEMBL28097852 | 0.77 | CDC25B (0.79) | GAAMAPTKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070155633-A1 | Diaromatic amine derivatives as antioxidants | LANXESS SOLUTIONS US INC. | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070155633-A1 | Diaromatic amine derivatives as antioxidants | C9, C5, C1S | GAA 4708/4885MAPT 3003/4885KDM4E 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.